Hayenga Heather N, Bishop Andrew J, Wardak Zabi, Sen Chandra, Mickey Bruce
Department of Bioengineering, University of Texas at Dallas, Richardson, Texas, USA.
Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
World Neurosurg. 2019 Mar;123:68-75. doi: 10.1016/j.wneu.2018.11.173. Epub 2018 Nov 29.
Hemangiopericytomas (HPCs) are rare vascular tumors that resemble meningiomas on imaging and have a high rate of local recurrence and metastases. There remains a paucity of data to guide management decisions of intraspinal dissemination of HPCs in the literature, and none specifically related to anaplastic HPCs.
We report a case of a 34-year-old woman with locally and distantly recurrent anaplastic HPC (World Health Organization grade III). She initially presented with tinnitus in her right ear. A well-circumscribed, contrast-enhancing lesion was identified in the right cerebellopontine angle. Treatment consisted of subtotal resection and postoperative radiation therapy (RT) to a dose of 60 Gy in 30 fractions. After a 3-year disease-free interval, 7 lesions recurred intra- and extracranially. The extracranial lesions were drop metastases of the original HPC through the cerebrospinal fluid into the spinal canal. Of note, fluorodeoxyglucose positron emission tomography (PET)/computed tomography scan was not sensitive enough to detect these new lesions. The intracranial recurrence was on the edge of the prior radiotherapy field, representing a marginal failure having received less than 50 Gy. The intracranial recurrences were treated with salvage gamma knife stereotactic radiosurgery (SRS) with local control. She underwent intradural extramedullary hemilaminectomy of a thoracic spine metastasis followed by fractionated proton beam therapy (PBT) with a boost to unresected lesions. Within a few months of PBT, she became pregnant. Pregnancy did not affect recurrence or ameliorate tumor growth.
This case report discusses the role genetics, adjuvant RT, SRS, magnetic resonance imaging, and PET scan played in this unique clinical scenario of anaplastic HPC.
血管外皮细胞瘤(HPCs)是一种罕见的血管肿瘤,在影像学上类似于脑膜瘤,局部复发和转移率较高。文献中仍缺乏指导HPCs脊髓内播散治疗决策的数据,且没有专门针对间变性HPCs的数据。
我们报告一例34岁女性,患有局部和远处复发的间变性HPC(世界卫生组织III级)。她最初表现为右耳鸣。在右侧桥小脑角发现一个边界清晰、有强化的病变。治疗包括次全切除和术后放疗,剂量为60 Gy,分30次进行。经过3年无病期后,颅内和颅外有7个病灶复发。颅外病灶是原始HPC通过脑脊液进入椎管形成的播散性转移。值得注意的是,氟脱氧葡萄糖正电子发射断层扫描(PET)/计算机断层扫描对检测这些新病灶的敏感性不足。颅内复发位于先前放疗野的边缘,属于接受剂量小于50 Gy的边缘性失败。颅内复发采用挽救性伽玛刀立体定向放射外科治疗(SRS)并实现局部控制。她接受了胸椎转移瘤的硬脊膜外髓外半椎板切除术,随后对未切除病灶进行分次质子束治疗(PBT)并给予剂量增加。在PBT治疗后的几个月内,她怀孕了。怀孕未影响复发情况,也未改善肿瘤生长。
本病例报告讨论了遗传学、辅助放疗、SRS、磁共振成像和PET扫描在这种间变性HPC独特临床病例中的作用。